Dihydroboldenone vs Testosterone Enanthate
A side-by-side research comparison of Dihydroboldenone and Testosterone Enanthate across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Dihydroboldenone | Testosterone Enanthate |
|---|---|---|
| Full name | Dihydroboldenone (1-Testosterone / DHB) | Testosterone Enanthate (Long-Ester Testosterone) |
| Category | Anabolic Steroids | Anabolic Steroids |
| Status | Not medically approved (controlled substance) | FDA-approved drug (controlled substance) |
| Mechanism | DHB is boldenone with the double bond reduced, giving a highly anabolic, non-aromatizing steroid that does not convert to estrogen or DHT. It has strong androgen-receptor binding and promotes dry, lean gains. | A testosterone molecule attached to an enanthate ester that slows release from the injection site. Once cleaved, testosterone binds androgen receptors to increase muscle protein synthesis, nitrogen retention, red blood cell production, and secondary sexual characteristics. |
| Molecular weight | 288.4 Da (base) | 400.6 Da |
| Half-life | Varies by ester | ~4.5-5 days |
| Bioavailability | Intramuscular injection | Intramuscular/subcutaneous injection |
| Typical dose | Lean-gain cycles (non-medical) | TRT ~100-200 mg/week (medical) |
| Frequency | Per ester | 1-2x weekly |
| Route | Intramuscular injection | Intramuscular or subcutaneous injection |
Dihydroboldenone reported benefits
- Strong lean mass gains
- No estrogen conversion
- No DHT conversion
- Dry, hard appearance
Testosterone Enanthate reported benefits
- Restores testosterone in deficiency (medical)
- Increased muscle mass and strength
- Improved libido and mood (when deficient)
- Increased bone density
- Stable long-acting levels
Related comparisons
Research and educational reference only. Not medical advice.